Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
35,913,464
-
Shares change
-
+2,609,364
-
Total reported value, excl. options
-
$1,047,948,698
-
Value change
-
+$80,679,718
-
Number of buys
-
62
-
Number of sells
-
-39
-
Price
-
$29.18
Significant Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) as of Q2 2014
124 filings reported holding PTLA - PORTOLA PHARMACEUTICALS INC - COM as of Q2 2014.
PORTOLA PHARMACEUTICALS INC - COM (PTLA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,913,464 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT CO LLP (5,122,539 shares), FMR LLC (4,289,950 shares), Temasek Holdings (Private) Ltd (4,233,568 shares), FRANKLIN RESOURCES INC (1,635,701 shares), EAGLE ASSET MANAGEMENT INC (1,618,521 shares), Sectoral Asset Management Inc (1,365,152 shares), ORBIMED ADVISORS LLC (1,361,600 shares), VANGUARD GROUP INC (1,341,579 shares), JPMORGAN CHASE & CO (1,318,553 shares), and BlackRock Fund Advisors (1,299,323 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.